A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Clinical trial NCT06017258 · RECRUITING

Trial details

NCT number: NCT06017258
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Acute Myeloid Leukemia Relapsed Acute Myeloid Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory

Start date: 2023-09-01
Primary completion: 2026-12-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.